[e-drug] Tuberculosis Prescription Practices In Private And Public Sector In India (2)

e-drug
1

E-DRUG: Tuberculosis Prescription Practices In Private And Public Sector In India (2)

Dear colleagues

Likewise in Sudan - we found discrepancies and non- adherence to TB treatment protocol in prescribing first-line anti tuberculosis drugs. These were obvious in the private sector more than in the public one. The problem of private sector needs more attention as many patients seek medical care in this sector.

Abubaker Ibrahim Elbur
assistant professor of clinical pharmacy
Taif university
KSA

2

E-DRUG: Tuberculosis Prescription Practices In Private And Public Sector In India (3)
---------------------------------------------------------------------------

[Apologies to those who couldn't locate the study on the web. It is available at the following link - DB]

http://www.scopemed.org/fulltextpdf.php?mno=36915

Do you have a reference to the Sudan study?
Thank you

Best wishes

3

E-DRUG: Tuberculosis Prescription Practices In Private And Public Sector In India (4)
--------------------------------------------------------------------------

[This message is with regard to access to the Sudan TB study - the link sent earlier was for the India study. Those who wish a copy of the abstract or paper will need to write to Abubaker directly - don't just hit 'Reply' to this message that will reply to E-DRUG. DB]

Dear All

Yes it had been published in a Sudanese local journal (AlBuhuth)

"Antituberculosis Drugs, study of prescriptions, in Omdurman".  Unfortunately it cannot be access in the internet but if you're interested on it I can send the scanned abstract later.

Kind Regards

Abubaker Ibrahim Elbur
Assistant Professor of Clinical Pharmacy
College of Pharmacy
University of Taif
KSA

4

E-DRUG: Tuberculosis Prescription Practices In Private And Public Sector In India (5)
---------------------------------------------------------------------------

Colleagues,

In addition [to the previously mentioned study in India], OIG Global Fund, recently published a final report on India Grants - 24 April 2013 - Report No: GF-OIG-13-011 available on http://www.theglobalfund.org/en/oig/reports/.

A relevant section on TB regimens (DOTS) used in India is on page 13-14.

Is India too big to change? I need to know why the WHO office in India was not pushing more in the past 10 years.

Pascal Verhoeven
MPH/pharmacist
Lao PDR
Mobile
+856(0)2077596717
+856(0)2097141783